Literature DB >> 15993221

Sample size and the ethics of non-inferiority trials.

John H Powers, Charles K Cooper, Daphne Lin, David B Ross.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Substances：

Year:  2005        PMID： 15993221     DOI： 10.1016/S0140-6736(05)66817-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Difficulties in demonstrating superiority of an antibiotic for multidrug-resistant bacteria in nonrandomized studies.

Authors:  Kristen A Stafford; Mallory Boutin; Scott R Evans; Anthony D Harris
Journal:  Clin Infect Dis       Date:  2014-06-30       Impact factor: 9.079

2.  Comment: Fundamentals and Innovation in Antibiotic Trials.

Authors:  Scott R Evans; Dean Follmann
Journal:  Stat Biopharm Res       Date:  2015-12-17       Impact factor: 1.452

3.  Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR).

Authors:  Scott R Evans; Daniel Rubin; Dean Follmann; Gene Pennello; W Charles Huskins; John H Powers; David Schoenfeld; Christy Chuang-Stein; Sara E Cosgrove; Vance G Fowler; Ebbing Lautenbach; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2015-06-25       Impact factor: 9.079

4.  Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12).

Authors:  Teresa Sanz-Cuesta; Paloma González-Escobar; Rosario Riesgo-Fuertes; Sofía Garrido-Elustondo; Isabel del Cura-González; Jesús Martín-Fernández; Esperanza Escortell-Mayor; Francisco Rodríguez-Salvanés; Marta García-Solano; Rocío González-González; María Ángeles Martín-de la Sierra-San Agustín; Carmen Olmedo-Lucerón; María Luisa Sevillano Palmero; Carmen Mateo-Ruiz; Beatriz Medina-Bustillo; Antonio Valdivia-Pérez; Francisca García-de Blas-González; José Enrique Mariño-Suárez; Ricardo Rodríguez-Barrientos; Gloria Ariza-Cardiel; Luisa María Cabello-Ballesteros; Elena Polentinos-Castro; Milagros Rico-Blázquez; Ma Teresa Rodríguez-Monje; Sonia Soto-Díaz; Susana Martín-Iglesias; Ramón Rodríguez-González; Irene Bretón-Lesmes; María Vicente-Herrero; Jesús Sánchez-Díaz; Tomás Gómez-Gascón; Mercedes Drake-Canela; Ángel Asúnsolo-del Barco
Journal:  BMC Public Health       Date:  2012-05-31       Impact factor: 3.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.